Back
ResMed Quote, Financials, Valuation and Earnings
Sponsored
RMD
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
45
RMD
ResMed
Last Price:
231.40
Seasonality Move:
10.61%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.ResMed Price Quote
$231.40
-4.04 (-1.72%)
(Updated: November 14, 2024 at 5:15 PM ET)
ResMed Key Stats
Sell
45
ResMed (RMD)
is a Sell
Day range:
$235.36 - $247.73
52-week range:
$144.29 - $260.49
Dividend yield:
0.82%
P/E ratio:
35.72
P/S ratio:
7.59
P/B ratio:
6.99%
Volume:
987.9K
Avg. volume:
1M
1-year change:
64.74%
Market cap:
$36.3B
Revenue:
$4.7B
EPS:
$7.55
How Much Does ResMed Make?
Is ResMed Growing As A Company?
ResMed Stock Price Performance
What Is ResMed 52-Week High & Low?
ResMed Price To Free Cash Flow
-
Is ResMed Stock Overvalued?
ResMed is trading at a price to free cash flow ratio of 27.08 -
Is ResMed Stock Undervalued?
ResMed EV to Free Cash Flow ratio is 27.13 -
What Is ResMed’s Price Earnings Growth Ratio?
RMD PEG ratio is 1.45 -
Is ResMed Trading At A Premium To Earnings?
ResMed EV to EBIT ratio is 25.94
Is It Risky To Buy ResMed?
Is ResMed Cash Flow Positive?
ResMed Return On Invested Capital
ResMed Earnings Date & Stock Price
-
What Is ResMed's Stock Price Today?
A single share of RMD can be purchased today for 235.44 -
What Is ResMed’s Stock Symbol?
ResMed trades on the nyse under the ticker symbol: RMD -
When Is ResMed’s Next Earnings Date?
The next quarterly earnings date for ResMed is scheduled on January 24, 2025 -
When Is RMD's next ex-dividend date?
ResMed's next ex-dividend date is November 7, 2024 -
How To Buy ResMed Stock?
You can buy ResMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ResMed Competitors
ResMed Dividend Yield
ResMed Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 41.61% | 7.69% |
Revenue: | 11.09% | 3.52% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 1 |
Price Target: | 253.39 |
Upside from Last Price: | 7.63% |